|
DE296075C
(de)
|
|
|
|
|
|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
JPS61100519A
(ja)
|
1984-10-23 |
1986-05-19 |
Shin Etsu Chem Co Ltd |
医薬用硬質カプセル
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
ES2099158T3
(es)
|
1990-04-14 |
1997-05-16 |
New England Medical Center Inc |
Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
|
|
US5462928A
(en)
|
1990-04-14 |
1995-10-31 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
EP0940468A1
(de)
|
1991-06-14 |
1999-09-08 |
Genentech, Inc. |
Änderliches Gebiet einer humanisierter Antikörper
|
|
ATE199016T1
(de)
|
1991-10-22 |
2001-02-15 |
New England Medical Center Inc |
Inhibitoren der dipeptidyl-aminopeptidase vom typ-iv
|
|
US6825169B1
(en)
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
MX9206628A
(es)
|
1991-11-22 |
1993-05-01 |
Boehringer Ingelheim Pharma |
Ester de prolinaboronato y metodo para su preparacion.
|
|
US5431917A
(en)
|
1992-10-08 |
1995-07-11 |
Japan Elanco Company, Ltd. |
Hard capsule for pharmaceutical drugs and method for producing the same
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5543396A
(en)
|
1994-04-28 |
1996-08-06 |
Georgia Tech Research Corp. |
Proline phosphonate derivatives
|
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
US20020006899A1
(en)
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
|
AU4721897A
(en)
|
1996-10-25 |
1998-05-22 |
Tanabe Seiyaku Co., Ltd. |
Tetrahydroisoquinoline derivatives
|
|
US6011155A
(en)
|
1996-11-07 |
2000-01-04 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
US5736151A
(en)
|
1996-12-09 |
1998-04-07 |
Pharmacia & Upjohn Company |
Antibiotic oil suspensions
|
|
ES2425559T5
(es)
|
1997-01-07 |
2018-02-02 |
Amylin Pharmaceuticals, Llc |
Composiciones farmacéuticas que comprenden las exendinas y los agonistas de las mismas
|
|
DE122005000026I1
(de)
|
1997-04-07 |
2005-08-04 |
Genentech Inc |
Anti-VEGF Antik¦rper.
|
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
|
US6040145A
(en)
|
1997-05-07 |
2000-03-21 |
Tufts University |
Potentiation of the immune response
|
|
BR9813233A
(pt)
|
1997-09-29 |
2000-08-22 |
Point Therapeutics Inc |
Estimulação de células hematopoéticas in vitro
|
|
EP1043328B1
(de)
|
1997-11-18 |
2008-03-19 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Neue physiologisch aktive substanz sulphostin, herstellung und verwendung derselben
|
|
ES2317688T3
(es)
|
1998-01-29 |
2009-04-16 |
Amgen Inc. |
Moduladores ppar-gamma.
|
|
US6583157B2
(en)
|
1998-01-29 |
2003-06-24 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
WO1999038501A2
(en)
|
1998-02-02 |
1999-08-05 |
Trustees Of Tufts College |
Method of regulating glucose metabolism, and reagents related thereto
|
|
US20020061839A1
(en)
|
1998-03-09 |
2002-05-23 |
Scharpe Simon Lodewijk |
Serine peptidase modulators
|
|
JP2002513762A
(ja)
|
1998-05-04 |
2002-05-14 |
ポイント セラピューティクス， インコーポレイテッド |
造血刺激
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
EP1084129B1
(de)
|
1998-06-05 |
2003-01-22 |
Point Therapeutics, Inc. |
Cyclische boroprolinverbindungen
|
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19834591A1
(de)
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
|
EP1104293A1
(de)
|
1998-08-21 |
2001-06-06 |
Point Therapeutics, Inc. |
Regulierung von substrat aktivität
|
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
JP3449253B2
(ja)
|
1998-10-29 |
2003-09-22 |
シオノギクオリカプス株式会社 |
硬質カプセルの製造方法
|
|
KR100458748B1
(ko)
|
1998-12-07 |
2004-12-03 |
더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 |
Ｇｌｐ-1 유사체
|
|
AU775925B2
(en)
|
1998-12-09 |
2004-08-19 |
La Jolla Pharmaceutical Company |
Molecular scaffolds acting as templates comprising carbamate linkages
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
JP2000191616A
(ja)
|
1998-12-24 |
2000-07-11 |
Senju Pharmaceut Co Ltd |
新規ジペプチジルアルデヒド誘導体およびそれを含有する医薬
|
|
KR100675711B1
(ko)
|
1999-01-14 |
2007-02-01 |
아밀린 파마슈티칼스, 인크. |
신규 엑센딘 아고니스트 제제 및 이의 투여 방법
|
|
JP3018186B1
(ja)
|
1999-03-09 |
2000-03-13 |
大阪大学長 |
抗炎症剤、単球系細胞の増殖抑制剤
|
|
GB9906715D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for promoting growth
|
|
GB9906714D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for improving fertility
|
|
US20050272652A1
(en)
|
1999-03-29 |
2005-12-08 |
Gault Victor A |
Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
|
|
JP3716901B2
(ja)
|
1999-04-14 |
2005-11-16 |
シオノギクオリカプス株式会社 |
セルロースエーテルフィルム
|
|
JP4121215B2
(ja)
|
1999-05-17 |
2008-07-23 |
財団法人微生物化学研究会 |
スルフォスチン類縁体、並びにスルフォスチン及びその類縁体の製造方法
|
|
AU781897B2
(en)
|
1999-05-25 |
2005-06-23 |
Point Therapeutics, Inc. |
Anti-tumor comprising boroproline compounds
|
|
US6107317A
(en)
|
1999-06-24 |
2000-08-22 |
Novartis Ag |
N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US6110949A
(en)
|
1999-06-24 |
2000-08-29 |
Novartis Ag |
N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US6172081B1
(en)
|
1999-06-24 |
2001-01-09 |
Novartis Ag |
Tetrahydroisoquinoline 3-carboxamide derivatives
|
|
IL147308A0
(en)
|
1999-06-30 |
2002-08-14 |
Tularik Inc |
Compounds for the modulation of pparγ activity and pharmaceutical compositions containing the same
|
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
US6617340B1
(en)
|
1999-07-29 |
2003-09-09 |
Novartis Ag |
N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
JP2003535034A
(ja)
|
1999-11-12 |
2003-11-25 |
ギルフォード ファーマシューティカルズ インコーポレイテッド |
ジペプチジルペプチダーゼｉｖ阻害剤並びにジペプチジルペプチダーゼｉｖ阻害剤の製造及び使用法
|
|
US20040152745A1
(en)
|
1999-11-12 |
2004-08-05 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
|
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
DK1741447T3
(da)
|
2000-01-21 |
2013-12-09 |
Novartis Ag |
Kombinationer omfattende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
|
|
EP1254113A1
(de)
|
2000-01-24 |
2002-11-06 |
Novo Nordisk A/S |
N-substituierte 2-cyanopyrrole und -pyrroline die inhibitoren des enzyms ddp-ivsind
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
|
EP1283735B2
(de)
|
2000-03-31 |
2012-10-24 |
Royalty Pharma Collection Trust |
Verbesserung der aktivität der inselzellen bei diabetes mellitus und dessen prävention
|
|
GB0010188D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
HUP0301146A3
(en)
|
2000-04-28 |
2004-08-30 |
Sankyo Co |
2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
|
|
WO2001082916A2
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Combination therapeutic compositions and methods of use
|
|
TW583185B
(en)
|
2000-06-13 |
2004-04-11 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
|
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
NZ523229A
(en)
|
2000-06-28 |
2004-10-29 |
Tularik Inc |
Quinolinyl and benzothiazolyl PPAR-gamma modulators
|
|
HUP0301622A3
(en)
|
2000-07-04 |
2006-05-29 |
Novo Nordisk As |
Purine derivatives inhibiting the enzyme dipeptidyl petidase iv (dpp-iv) and pharmaceutical compositions containing them
|
|
US7074794B2
(en)
|
2000-08-10 |
2006-07-11 |
Mitsubishi Pharma Corporation |
Proline derivatives and the use thereof as drugs
|
|
JP4329290B2
(ja)
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
脂肪族含窒素五員環化合物
|
|
AU9419601A
(en)
|
2000-10-06 |
2002-04-22 |
Tanabe Seiyaku Co |
Nitrogenous five-membered ring compounds
|
|
JP4329291B2
(ja)
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
含窒素五員環化合物
|
|
JP2004035574A
(ja)
|
2000-10-06 |
2004-02-05 |
Tanabe Seiyaku Co Ltd |
脂肪族含窒素五員環化合物
|
|
AUPR107800A0
(en)
|
2000-10-27 |
2000-11-23 |
University Of Sydney, The |
Peptide and nucleic acid molecule ii
|
|
TWI243162B
(en)
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
|
CA2433090A1
(en)
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
|
DE10100053A1
(de)
|
2001-01-02 |
2002-08-22 |
Keyneurotek Ag I G |
Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
|
|
US7229969B2
(en)
|
2001-01-02 |
2007-06-12 |
Imtm Gmbh |
Combinations of enzyme inhibitors and the use thereof
|
|
JP4170758B2
(ja)
|
2001-01-16 |
2008-10-22 |
日本化薬株式会社 |
骨髄抑制治療剤、感染症治療剤及び白血球数増加剤
|
|
JP4213390B2
(ja)
|
2001-02-02 |
2009-01-21 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
ATE366724T1
(de)
|
2001-02-02 |
2007-08-15 |
Takeda Pharmaceutical |
Kondensierte heterocyclische derivate
|
|
PT2298769E
(pt)
|
2001-02-24 |
2013-11-29 |
Boehringer Ingelheim Pharma |
Derivados de xantina, sua preparação e sua utilização como produto farmacêutico
|
|
JP2002265439A
(ja)
|
2001-03-08 |
2002-09-18 |
Mitsubishi Pharma Corp |
シアノピロリジン誘導体およびその医薬用途
|
|
DE60226723D1
(de)
|
2001-03-27 |
2008-07-03 |
Merck & Co Inc |
Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes
|
|
FR2822826B1
(fr)
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6890905B2
(en)
|
2001-04-02 |
2005-05-10 |
Prosidion Limited |
Methods for improving islet signaling in diabetes mellitus and for its prevention
|
|
GB0109146D0
(en)
|
2001-04-11 |
2001-05-30 |
Ferring Bv |
Treatment of type 2 diabetes
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US20030060494A1
(en)
|
2001-05-18 |
2003-03-27 |
Nobuyuki Yasuda |
Pharmaceutical use of N-carbamoylazole derivatives
|
|
JP2004535433A
(ja)
|
2001-06-20 |
2004-11-25 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病治療用のジペプチジルペプチダーゼ阻害薬
|
|
CA2450475A1
(en)
|
2001-06-20 |
2003-01-03 |
Linda Brockunier |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
WO2003002530A2
(en)
|
2001-06-27 |
2003-01-09 |
Smithkline Beecham Corporation |
Pyrrolidines as dipeptidyl peptidase inhibitors
|
|
ZA200300833B
(en)
|
2001-06-27 |
2004-02-10 |
Probiodrug Ag |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents.
|
|
DE60221983T2
(de)
|
2001-06-27 |
2008-05-15 |
Smithkline Beecham Corp. |
Fluorpyrrolidine als dipeptidyl-peptidase inhibitoren
|
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
|
DE10154689A1
(de)
|
2001-11-09 |
2003-05-22 |
Probiodrug Ag |
Substituierte Aminoketonverbindungen
|
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
|
AU2002322344C1
(en)
|
2001-06-27 |
2006-02-16 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
|
CA2418543A1
(en)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
|
|
ATE388951T1
(de)
|
2001-07-03 |
2008-03-15 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
SG143981A1
(en)
|
2001-08-31 |
2008-07-29 |
Semiconductor Energy Lab |
Laser irradiation method, laser irradiation apparatus, and method of manufacturing a semiconductor device
|
|
US6844316B2
(en)
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
|
DE10143840A1
(de)
|
2001-09-06 |
2003-03-27 |
Probiodrug Ag |
Neue Inhibitoren der Dipeptidylpeptidase I
|
|
US20040259883A1
(en)
|
2001-09-14 |
2004-12-23 |
Hiroshi Sakashita |
Thiazolidine derivative and medicinal use thereof
|
|
JP2005509603A
(ja)
|
2001-09-19 |
2005-04-14 |
ノボ ノルディスク アクティーゼルスカブ |
Ｄｐｐ−ｉｖ酵素の阻害剤であるヘテロ環化合物
|
|
GB0125445D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Protease Inhibitors
|
|
GB0125446D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Novel anti-diabetic agents
|
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
CN1604968A
(zh)
|
2001-10-31 |
2005-04-06 |
诺瓦提斯公司 |
基于tcf1基因多态性治疗糖尿病和相关病症的方法
|
|
US20030125304A1
(en)
|
2001-11-09 |
2003-07-03 |
Hans-Ulrich Demuth |
Substituted amino ketone compounds
|
|
US7236683B2
(en)
|
2001-11-15 |
2007-06-26 |
Macrovision Corporation |
Method and apparatus for providing or enhancing copy protection by adding selected negative-going and positive-going pulses in a video signal HBI
|
|
EP2769715A3
(de)
|
2001-11-26 |
2014-09-17 |
Trustees Of Tufts College |
Verfahren zur Behandlung von Autoimmunkrankheiten und damit zusammenhängende Reagenzien
|
|
EP2316470A3
(de)
|
2001-11-26 |
2011-08-24 |
Trustees Of Tufts College |
Peptidomimetikuminhibitoren von post-Prolin-spaltenden Enzymen
|
|
WO2003057144A2
(en)
|
2001-12-26 |
2003-07-17 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
|
US6725848B2
(en)
|
2002-01-18 |
2004-04-27 |
Detroit Diesel Corporation |
Method of controlling exhaust gas recirculation system based upon humidity
|
|
WO2003072528A2
(en)
|
2002-02-08 |
2003-09-04 |
Idun Pharmaceuticals, Inc. |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
PL372488A1
(en)
|
2002-02-13 |
2005-07-25 |
F.Hoffmann-La Roche Ag |
Novel pyridine- and quinoline-derivatives
|
|
CA2474578C
(en)
|
2002-02-13 |
2009-08-25 |
F. Hoffmann-La Roche Ag |
Novel pyridin- and pyrimidin-derivatives
|
|
US6906074B2
(en)
|
2002-02-22 |
2005-06-14 |
Nippon Zoki Pharmaceutical Co., Ltd. |
2-phenylpiperazine derivatives
|
|
EP1338595B1
(de)
|
2002-02-25 |
2006-05-03 |
Eisai Co., Ltd. |
Xanthin-Derivate als DPP-IV-Inhibitoren
|
|
JP2004043429A
(ja)
|
2002-02-25 |
2004-02-12 |
Eisai Co Ltd |
新規キサンチン誘導体およびｄｐｐｉｖ阻害剤
|
|
NZ534877A
(en)
|
2002-02-28 |
2006-05-26 |
Prosidion Ltd |
Glutaminyl based DPIV inhibitors
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
WO2003080633A1
(en)
|
2002-03-25 |
2003-10-02 |
Nippon Kayaku Kabushiki Kaisha |
Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
|
|
ATE373660T1
(de)
|
2002-03-25 |
2007-10-15 |
Merck & Co Inc |
Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
|
|
JP4329381B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP4329382B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
US20040106802A1
(en)
|
2002-04-08 |
2004-06-03 |
Torrent Pharmaceuticals Ltd. |
Novel compounds and therapeutic uses thereof
|
|
WO2003084940A1
(en)
|
2002-04-08 |
2003-10-16 |
Alangudi Sankaranarayanan |
Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
|
|
JP2003300977A
(ja)
|
2002-04-10 |
2003-10-21 |
Sumitomo Pharmaceut Co Ltd |
キサンチン誘導体
|
|
AU2003235913A1
(en)
|
2002-05-09 |
2003-11-11 |
Taisho Pharmaceutical Co., Ltd. |
Cyanopyrrolidine derivatives
|
|
JP2004026820A
(ja)
|
2002-05-09 |
2004-01-29 |
Taisho Pharmaceut Co Ltd |
ジペプチジルペプチダーゼｉｖ阻害剤
|
|
JP2003327532A
(ja)
|
2002-05-10 |
2003-11-19 |
Takeda Chem Ind Ltd |
ペプチダーゼ阻害剤
|
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
SI1513519T1
(sl)
|
2002-06-03 |
2009-06-30 |
Novartis Ag |
Uporaba substituiranih cianopirolidinov za zdravljenje hiperlipidemije
|
|
US6710040B1
(en)
|
2002-06-04 |
2004-03-23 |
Pfizer Inc. |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
|
|
AU2003233010A1
(en)
|
2002-06-04 |
2003-12-19 |
Pfizer Products Inc. |
Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
|
|
MXPA04011958A
(es)
|
2002-06-04 |
2005-03-31 |
Pfizer Prod Inc |
Amidas ciclicas fluoradas como inhibidores de la dipeptidil peptidasa iv.
|
|
US20060100199A1
(en)
|
2002-06-06 |
2006-05-11 |
Seiji Yoshikawa |
Novel condensed imidazole derivatives
|
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
|
JP2004026678A
(ja)
|
2002-06-24 |
2004-01-29 |
Microbial Chem Res Found |
２型糖尿病治療剤
|
|
AU2003265264A1
(en)
|
2002-07-09 |
2004-01-23 |
Point Therapeutics, Inc. |
Methods and compositions relating to isoleucine boroproline compounds
|
|
WO2004007446A1
(ja)
|
2002-07-10 |
2004-01-22 |
Yamanouchi Pharmaceutical Co., Ltd. |
新規なアゼチジン誘導体又はその塩
|
|
AU2003251869A1
(en)
|
2002-07-15 |
2004-02-02 |
Merck & Co., Inc. |
Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
TW200401635A
(en)
|
2002-07-23 |
2004-02-01 |
Yamanouchi Pharma Co Ltd |
2-Cyano-4-fluoropyrrolidine derivative or salt thereof
|
|
JP4153911B2
(ja)
|
2002-07-29 |
2008-09-24 |
田辺三菱製薬株式会社 |
ジペプチジルペプチダーゼｉｖの立体構造
|
|
EP1527049B8
(de)
|
2002-08-08 |
2008-10-29 |
Takeda Pharmaceutical Company Limited |
Kondensierte heterozyklische verbindungen als petidase inhibitoren
|
|
JP4542757B2
(ja)
|
2002-08-08 |
2010-09-15 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
EP3424926A1
(de)
|
2002-08-21 |
2019-01-09 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
8-[3-amino-piperidin-1-yl]-xanthine, deren herstellung und deren verwendung als arzneimittel
|
|
DE10238243A1
(de)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2004019352A1
(ja)
|
2002-08-26 |
2004-03-04 |
Matsushita Electric Industrial Co., Ltd. |
マルチフェーズ用磁性素子とその製造方法
|
|
EP1535907A4
(de)
|
2002-08-29 |
2006-11-29 |
Taisho Pharmaceutical Co Ltd |
Benzolsulfonat eines 4-fluor-2-cyanopyrrolidinderivats
|
|
US8895541B2
(en)
|
2002-09-04 |
2014-11-25 |
James A. Carnazza |
Methods for inhibiting the development of huntington's disease
|
|
WO2004024184A1
(ja)
|
2002-09-11 |
2004-03-25 |
Takeda Pharmaceutical Company Limited |
徐放性製剤
|
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US7238724B2
(en)
|
2002-09-19 |
2007-07-03 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US20040121964A1
(en)
|
2002-09-19 |
2004-06-24 |
Madar David J. |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
DE60315687T2
(de)
|
2002-10-07 |
2008-06-05 |
Merck & Co., Inc. |
Antidiabetische heterocyclische beta-aminoverbindungen als inhibitoren von dipeptidylpeptidase
|
|
AU2003269850A1
(en)
|
2002-10-08 |
2004-05-04 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
|
BR0315381A
(pt)
|
2002-10-18 |
2005-08-23 |
Merck & Co Inc |
Composto ou um sal farmaceuticamente aceitável deste, composição farmacêutica, e, métodos para inibir a atividade da enzima dipeptidil peptidase-iv em um mamìfero em necessidade disto, para tratar diabetes em um mamìfero em necessidade disto, para tratar diabete não dependente de insulina (tipo 2) em um mamìfero em necessidade disto, para tratar hiperglicemia em um mamìfero em necessidade disto, para tratar a obesidade em um mamìfero em necessidade disto, para tratar um ou mais distúrbios de lipìdios selecionados do grupo de dislipidemia, hiperlipidemia, hipertrigliceridemia, hipercolesterolemia, hdl baixo e ldl alto em um mamìfero em necessidade disto, e para tratar em um mamìfero em necessidade disto uma ou mais condições
|
|
ATE469645T1
(de)
|
2002-10-23 |
2010-06-15 |
Bristol Myers Squibb Co |
Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
|
|
WO2004041795A1
(en)
|
2002-10-30 |
2004-05-21 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
|
AU2003280680A1
(en)
|
2002-11-01 |
2004-06-18 |
Sumitomo Pharmaceuticals Co., Ltd. |
Xanthine compound
|
|
PL376822A1
(pl)
|
2002-11-07 |
2006-01-09 |
Merck & Co., Inc. |
Pochodne fenyloalaniny jako inhibitory dipeptydylopeptydazy do leczenia lub zapobiegania cukrzycy
|
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP1565437A1
(de)
|
2002-11-18 |
2005-08-24 |
Pfizer Products Inc. |
Dipeptidylpeptidase iv inhibierende fluorierte cyclische amide
|
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE10256264A1
(de)
|
2002-12-03 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
US7109192B2
(en)
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
|
AU2003297564A1
(en)
|
2002-12-04 |
2004-06-23 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
US7420079B2
(en)
|
2002-12-09 |
2008-09-02 |
Bristol-Myers Squibb Company |
Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
|
|
EP1572196B1
(de)
|
2002-12-10 |
2008-08-13 |
Novartis AG |
Kombinationen von einem dpp-iv inhibitor und einem ppar- alpha agonist
|
|
CA2508947A1
(en)
|
2002-12-20 |
2004-07-15 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
EP1589969A4
(de)
|
2003-01-17 |
2008-08-13 |
Merck & Co Inc |
3-amino-4-phenylbutansäurederivateals dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
|
|
JP2004244412A
(ja)
|
2003-01-20 |
2004-09-02 |
Kotobuki Seiyaku Kk |
４位に置換基を有する２−シアノピロリジン誘導体及びその製造方法並びにそれを含有する薬剤
|
|
JP4345313B2
(ja)
|
2003-01-24 |
2009-10-14 |
株式会社日立製作所 |
ポリシーに基づいたストレージシステムの運用管理方法
|
|
US7345180B2
(en)
|
2003-01-31 |
2008-03-18 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Compound inhibiting dipeptidyl peptidase IV
|
|
EP1592689A4
(de)
|
2003-01-31 |
2008-12-24 |
Merck & Co Inc |
3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
|
|
WO2004071454A2
(en)
|
2003-02-13 |
2004-08-26 |
Guilford Pharmaceuticals Inc. |
Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
|
|
WO2004076434A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
WO2004076433A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
AR043515A1
(es)
|
2003-03-19 |
2005-08-03 |
Merck & Co Inc |
Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica
|
|
WO2004085661A2
(en)
|
2003-03-24 |
2004-10-07 |
Merck & Co., Inc |
Process to chiral beta-amino acid derivatives
|
|
CN1894234A
(zh)
|
2003-03-25 |
2007-01-10 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
|
WO2004087650A2
(en)
|
2003-03-27 |
2004-10-14 |
Merck & Co. Inc. |
Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
|
|
WO2004092128A1
(en)
|
2003-04-10 |
2004-10-28 |
Smithkline Beecham Corporation |
Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
|
|
JPWO2004096806A1
(ja)
|
2003-04-30 |
2006-07-13 |
大日本住友製薬株式会社 |
縮合イミダゾール誘導体
|
|
EP1622870A2
(de)
|
2003-05-05 |
2006-02-08 |
Prosidion Ltd. |
Glutaminylbasierte dp-iv-inhibitoren
|
|
US20040224995A1
(en)
|
2003-05-09 |
2004-11-11 |
University Of North Texas Health Science Center At Fort Worth |
Neuroprotective effects of PPARy agonists against cellular oxidative insults
|
|
CN1787823A
(zh)
|
2003-05-14 |
2006-06-14 |
麦克公司 |
作为二肽基肽酶抑制剂用于治疗或预防糖尿病的3－氨基－4－苯基丁酸衍生物
|
|
EP1625122A1
(de)
|
2003-05-14 |
2006-02-15 |
Takeda San Diego, Inc. |
Dipeptidylpeptidase-hemmer
|
|
EP1627870A1
(de)
|
2003-05-15 |
2006-02-22 |
Taisho Pharmaceutical Co., Ltd |
Cyanofluorpyrrolidinderivativ
|
|
EP1631680A2
(de)
|
2003-05-21 |
2006-03-08 |
Bayer HealthCare AG |
Diagnostika und therapeutika für dipeptidylpeptidase iv (dpp4) assoziierte erkrangkungen
|
|
EP1631679A2
(de)
|
2003-05-21 |
2006-03-08 |
Bayer HealthCare AG |
Diagnostika und therapeutika, die mit der dipeptidylpeptidase 7 (dpp7) assoziiert sind
|
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
WO2004110436A1
(en)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
EP1635832A2
(de)
|
2003-06-06 |
2006-03-22 |
Merck & Co., Inc. |
Kombinationstherapie zur behandlung von diabetes
|
|
AU2003902946A0
(en)
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
JP4579239B2
(ja)
|
2003-06-17 |
2010-11-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療または予防するためのジペプチジルペプチダーゼ阻害剤としてのシクロヘキシルグリシン誘導体
|
|
DE10327439A1
(de)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
EA009591B1
(ru)
|
2003-06-20 |
2008-02-28 |
Ф.Хоффманн-Ля Рош Аг |
Производные пиридо[2,1-а]изохинолина в качестве ингибиторов dpp-iv
|
|
CN101090901B
(zh)
|
2003-06-20 |
2010-12-15 |
霍夫曼-拉罗奇有限公司 |
作为dpp-iv抑制剂的六氢吡啶并异喹啉类
|
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
|
JP2005023038A
(ja)
|
2003-07-04 |
2005-01-27 |
Taisho Pharmaceut Co Ltd |
慢性腎疾患治療薬
|
|
EP1654226B1
(de)
|
2003-07-21 |
2008-10-22 |
SmithKline Beecham Corporation |
(2s,4s)-4-fluor-1-[4-fluor-beta-(4-fluorphenyl)-l-phenylalanyl]-2-pyrrolidincarbonitril-p-toluolsulfonsäuresalz und wasserfreie kristalline formen davon
|
|
US7008957B2
(en)
|
2003-07-25 |
2006-03-07 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
|
|
US7094800B2
(en)
|
2003-07-25 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Cyanopyrrolidides, process for their preparation and their use as medicaments
|
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
|
US20050065183A1
(en)
|
2003-07-31 |
2005-03-24 |
Indranil Nandi |
Fexofenadine composition and process for preparing
|
|
CA2533893A1
(en)
|
2003-07-31 |
2005-02-10 |
Merck & Co., Inc. |
Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
DE10337074A1
(de)
|
2003-08-12 |
2005-03-17 |
Keyneurotek Ag |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention von chronischen neurodegenerativen Erkrankungen
|
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
ZA200602051B
(en)
|
2003-08-13 |
2007-10-31 |
Takeda Pharmaceutical |
4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
|
|
WO2005019168A2
(en)
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
|
JPWO2005021550A1
(ja)
|
2003-08-29 |
2006-10-26 |
大日本住友製薬株式会社 |
二環性ピラゾール誘導体
|
|
HU227684B1
(en)
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
|
CN100457108C
(zh)
|
2003-09-02 |
2009-02-04 |
默克公司 |
一种二肽基肽酶iv抑制剂的磷酸盐新晶体
|
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
WO2005030751A2
(en)
|
2003-09-08 |
2005-04-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
JP2007505121A
(ja)
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
|
GB0321100D0
(en)
|
2003-09-09 |
2003-10-08 |
Celltech R&D Ltd |
Biological products
|
|
PE20050948A1
(es)
|
2003-09-09 |
2005-12-16 |
Japan Tobacco Inc |
Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv
|
|
US20070021430A1
(en)
|
2003-09-23 |
2007-01-25 |
Chen Alex M |
Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
|
EP1671649B1
(de)
|
2003-10-03 |
2011-11-23 |
Takeda Pharmaceutical Company Limited |
Dipeptidylpeptidase-IV-Inhibitoren zur Behandlung von Diabetes-Patienten mit Sekundärversagen durch Sulfonylharnstoffe
|
|
WO2005033099A2
(en)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
DE10348044A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
DE10348022A1
(de)
|
2003-10-15 |
2005-05-25 |
Imtm Gmbh |
Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200519105A
(en)
|
2003-10-20 |
2005-06-16 |
Lg Life Science Ltd |
Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
|
EP1684786A4
(de)
|
2003-10-24 |
2007-12-12 |
Merck & Co Inc |
Verbessertung der spiegel des wachstumshormons mit einem dipeptidyl-peptidase-iv-hemmer und einem wachstumshormon-sekretagog
|
|
CA2540225C
(en)
|
2003-10-31 |
2012-03-06 |
Takeda Pharmaceutical Company Limited |
Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
|
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
|
WO2005044195A2
(en)
|
2003-11-04 |
2005-05-19 |
Merck & Co., Inc. |
Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
US7317109B2
(en)
|
2003-11-12 |
2008-01-08 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7674913B2
(en)
|
2003-11-12 |
2010-03-09 |
Phenomix Corporation |
Heterocyclic boronic acid compounds
|
|
US7767828B2
(en)
|
2003-11-12 |
2010-08-03 |
Phenomix Corporation |
Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US20070149451A1
(en)
|
2003-11-17 |
2007-06-28 |
Holmes David G |
Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
|
|
KR20150028829A
(ko)
|
2003-11-17 |
2015-03-16 |
노파르티스 아게 |
디펩티딜 펩티다제 ⅳ 억제제의 용도
|
|
WO2005051949A1
(ja)
|
2003-11-26 |
2005-06-09 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規縮合イミダゾール誘導体
|
|
DE10355304A1
(de)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7504423B2
(en)
|
2003-12-11 |
2009-03-17 |
Mitsubishi Tanabe Pharma Corporation |
α-amino acid derivatives and use thereof as medicines
|
|
WO2005058849A1
(en)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them
|
|
US7217711B2
(en)
|
2003-12-17 |
2007-05-15 |
Boehringer Ingelheim International Gmbh |
Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2005072530A1
(en)
|
2004-01-16 |
2005-08-11 |
Merck & Co., Inc. |
Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
|
|
EP1559419A1
(de)
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmazeutische Darreichungsformen enthaltend Metformin und ein Fibrat, sowie deren Herstellungsprozesse
|
|
KR20050076924A
(ko)
|
2004-01-26 |
2005-07-29 |
삼성전자주식회사 |
양방향 통신이 가능한 ｉ2ｃ 통신시스템 및 그 방법
|
|
US7230002B2
(en)
|
2004-02-03 |
2007-06-12 |
Glenmark Pharmaceuticals Ltd. |
Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
|
|
WO2005075426A1
(en)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
|
AU2005215136A1
(en)
|
2004-02-20 |
2005-09-01 |
Novartis Ag |
DPP-IV inhibitors for treating neurodegeneration and cognitive disorders
|
|
AU2005217642B2
(en)
|
2004-02-23 |
2012-04-12 |
Trustees Of Tufts College |
Lactams as conformationally constrained peptidomimetic inhibitors
|
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
|
AU2005216970B2
(en)
|
2004-02-23 |
2011-07-07 |
Trustees Of Tufts College |
Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
|
|
US7348346B2
(en)
|
2004-03-08 |
2008-03-25 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US20050215603A1
(en)
|
2004-03-08 |
2005-09-29 |
Irini Akritopoulou-Zanze |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
EP1722789A2
(de)
|
2004-03-08 |
2006-11-22 |
Amgen Inc. |
Therapeutische modulation der ppar (gamma) aktivität
|
|
US7687504B2
(en)
|
2004-03-09 |
2010-03-30 |
National Health Research Institutes |
Pyrrolidine compounds
|
|
US20070093492A1
(en)
|
2004-03-09 |
2007-04-26 |
Weir-Torn Jiaang |
Pyrrolidine derivatives
|
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
|
KR101071390B1
(ko)
|
2004-03-15 |
2011-10-07 |
다케다 야쿠힌 고교 가부시키가이샤 |
디펩티딜 펩티다제 억제제
|
|
RS52365B
(en)
|
2004-03-16 |
2012-12-31 |
Boehringer Ingelheim International Gmbh |
BENZOL DERIVATIVES SUBSTITUTED BY GLUCOPYRANOSIL, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS, THEIR USE AND THE PROCEDURE FOR THEIR PRODUCTION
|
|
US20050215882A1
(en)
|
2004-03-23 |
2005-09-29 |
The Regents Of The University Of Michigan |
Noninvasive method to determine fat content of tissues using MRI
|
|
TW200538122A
(en)
|
2004-03-31 |
2005-12-01 |
Bristol Myers Squibb Co |
Process for preparing a dipeptidyl peptidase Ⅳ inhibitor and intermediates employed therein
|
|
US7179809B2
(en)
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
|
EP1738754B1
(de)
|
2004-04-14 |
2015-07-15 |
Takeda Pharmaceutical Company Limited |
Feste pharmazeutische zubereitung
|
|
US7741082B2
(en)
|
2004-04-14 |
2010-06-22 |
Bristol-Myers Squibb Company |
Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
|
|
TW200536827A
(en)
|
2004-05-04 |
2005-11-16 |
Bristol Myers Squibb Co |
Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
|
|
AU2005247895A1
(en)
|
2004-05-18 |
2005-12-08 |
Merck & Co., Inc. |
Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
JP2008501714A
(ja)
|
2004-06-04 |
2008-01-24 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼインヒビター
|
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
|
US20080045466A1
(en)
|
2004-07-21 |
2008-02-21 |
Kenji Katsuno |
Progression Inhibitor For Disease Attributed To Abnormal Accumulation Of Liver Fat
|
|
NZ552605A
(en)
|
2004-07-23 |
2009-01-31 |
Electric Power Res Inst |
Flexible electromagnetic acoustic transducer sensor
|
|
US7054436B2
(en)
|
2004-08-02 |
2006-05-30 |
Sony Ericsson Mobile Communication, Ab |
Communication terminals with a dual use speaker for sensing background noise and generating sound, and related methods and computer program products
|
|
US20060046978A1
(en)
|
2004-08-31 |
2006-03-02 |
Morphochem Ag |
Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)
|
|
DE102004043944A1
(de)
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2006034435A2
(en)
|
2004-09-21 |
2006-03-30 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
|
AR051446A1
(es)
|
2004-09-23 |
2007-01-17 |
Bristol Myers Squibb Co |
Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
|
|
NZ554515A
(en)
|
2004-10-12 |
2009-12-24 |
Glenmark Pharmaceuticals Sa |
Novel dipeptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and process for their preparation
|
|
JP2008515978A
(ja)
|
2004-10-13 |
2008-05-15 |
ユニバーシティ オブ コネチカット |
カンナビネルジック脂質リガンド
|
|
US20060252670A1
(en)
|
2004-10-14 |
2006-11-09 |
Intercept Pharmaceuticals Inc. |
Method of reducing drug-induced adverse side effects in a patient
|
|
EP1656934A1
(de)
|
2004-11-12 |
2006-05-17 |
Cognis IP Management GmbH |
Verwendung von physiologisch aktiven Fettsäuren zur Behandlung von Lipodystrophie
|
|
RU2401267C2
(ru)
|
2004-11-30 |
2010-10-10 |
Ф.Хоффманн-Ля Рош Аг |
Замещенные производные бензохинолизина
|
|
TW200635599A
(en)
|
2004-12-16 |
2006-10-16 |
Boehringer Ingelheim Int |
Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
WO2006066747A1
(en)
|
2004-12-20 |
2006-06-29 |
F. Hoffmann-La Roche Ag |
4-aminopiperidine derivatives
|
|
US7411093B2
(en)
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
|
EP2805953B1
(de)
|
2004-12-21 |
2016-03-09 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl-Peptidase-Hemmer
|
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
AU2006226447B2
(en)
|
2005-03-22 |
2009-07-16 |
F. Hoffmann-La Roche Ag |
New salt and polymorphs of a DPP-IV inhibitor
|
|
JP4568361B2
(ja)
|
2005-04-22 |
2010-10-27 |
アラントス・ファーマシューティカルズ・ホールディング・インコーポレーテッド |
ジペプチジルペプチダーゼ−ｉｖ阻害剤
|
|
US7723309B2
(en)
|
2005-05-03 |
2010-05-25 |
Boehringer Ingelheim International Gmbh |
Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
US7644148B2
(en)
|
2005-05-16 |
2010-01-05 |
Hewlett-Packard Development Company, L.P. |
Historical data based workload allocation
|
|
US7521557B2
(en)
|
2005-05-20 |
2009-04-21 |
Bristol-Myers Squibb Company |
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
US20060264433A1
(en)
|
2005-05-23 |
2006-11-23 |
Backes Bradley J |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US20060270722A1
(en)
|
2005-05-31 |
2006-11-30 |
Thornberry Nancy A |
Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity
|
|
JPWO2007007757A1
(ja)
|
2005-07-12 |
2009-01-29 |
第一三共株式会社 |
ＰＰＡＲγアゴニストを含有する医薬組成物
|
|
MX2008001799A
(es)
|
2005-08-11 |
2008-04-16 |
Hoffmann La Roche |
Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
|
|
US7425633B2
(en)
|
2005-08-26 |
2008-09-16 |
National Health Research Institutes |
Pyrrolidine compounds
|
|
KR101331041B1
(ko)
|
2005-08-30 |
2013-11-20 |
애브비 인코포레이티드 |
디펩티딜 펩티다제-ｉｖ(ｄｐｐ-ｉｖ)의 억제제로서약제학적 조성물
|
|
EP1924571B1
(de)
|
2005-08-30 |
2010-10-13 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituierte benzyl-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
|
|
KR20080053369A
(ko)
|
2005-09-08 |
2008-06-12 |
베링거 인겔하임 인터내셔날 게엠베하 |
1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-(4-에티닐-벤질)-벤젠의 결정형, 이의 제조 방법 및 약제 제조를 위한이의 용도
|
|
AR056195A1
(es)
|
2005-09-15 |
2007-09-26 |
Boehringer Ingelheim Int |
Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
|
|
AT502717A1
(de)
|
2005-11-09 |
2007-05-15 |
Omnica Gmbh |
Pharmazeutische verwendung einer verbindung
|
|
WO2007054577A1
(en)
|
2005-11-14 |
2007-05-18 |
Probiodrug Ag |
Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
|
|
EP1966193B1
(de)
|
2005-12-21 |
2010-09-29 |
F. Hoffmann-La Roche AG |
Neues salz und polymorph des dpp-iv-hemmers
|
|
TWI384985B
(zh)
|
2005-12-22 |
2013-02-11 |
Takeda Pharmaceutical |
固體製劑
|
|
JP2009531291A
(ja)
|
2006-02-15 |
2009-09-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換ベンゾニトリル誘導体、それらの化合物を含有する医薬組成物、それらの使用及び製造方法
|
|
US20070239536A1
(en)
|
2006-04-05 |
2007-10-11 |
General Electric Company |
System and method for scheduling audience deficiency units and makegoods
|
|
PE20080697A1
(es)
|
2006-05-03 |
2008-08-05 |
Boehringer Ingelheim Int |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
ES2546181T3
(es)
|
2006-05-09 |
2015-09-21 |
Genzyme Corporation |
Métodos de tratar la enfermedad del hígado graso mediante inhibición de la síntesis de glucoesfingolípidos
|
|
PT2046292E
(pt)
|
2006-07-21 |
2010-04-26 |
Novartis Ag |
Formulações de éteres benzimidazolil-piridílicos
|
|
CA2667550A1
(en)
|
2006-10-27 |
2008-05-02 |
Boehringer Ingelheim International Gmbh |
Crystalline form of 4-(.beta.-d-glucopyranos-1-yl)-1-methyl-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
|
AR063569A1
(es)
|
2006-11-06 |
2009-02-04 |
Boehringer Ingelheim Int |
Derivados de benzil- benzonitrilo sustituidos con glucopiranosilo medicamentos que contienen a compuestos de este tipo su uso u procedimiento para su fabricacion
|
|
CA3007700A1
(en)
|
2006-11-09 |
2008-05-15 |
Boehringer Ingelheim International Gmbh |
Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
|
|
WO2008067378A2
(en)
|
2006-11-28 |
2008-06-05 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted phenyltetrazoles
|
|
US20100104636A1
(en)
|
2006-12-21 |
2010-04-29 |
Panagiotis Keramidas |
Pharmaceutical Compound and Composition
|
|
US20070172525A1
(en)
|
2007-03-15 |
2007-07-26 |
Ramesh Sesha |
Anti-diabetic combinations
|
|
WO2008128115A2
(en)
|
2007-04-13 |
2008-10-23 |
Somaxon Pharmaceuticals, Inc. |
Low-dose doxepin formulations
|
|
CA2693628A1
(en)
|
2007-07-11 |
2009-01-15 |
Cardoz Ab |
New combination for use in the treatment of imflammatory disorders
|
|
WO2009015179A1
(en)
|
2007-07-23 |
2009-01-29 |
Syndax Pharmaceuticals, Inc. |
Novel compounds and methods of using them
|
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术（上海）有限公司 |
白介素-22在治疗脂肪肝中的应用
|
|
WO2009097996A1
(de)
|
2008-02-07 |
2009-08-13 |
Sanofi-Aventis |
Verwendung von substituierten phenylimidazolidinen zur herstellung von arzneimitteln zur behandlung des metabolischen syndroms
|
|
EP2242747A1
(de)
|
2008-02-07 |
2010-10-27 |
Sanofi-Aventis |
Substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
|
|
WO2009111078A2
(en)
|
2008-03-06 |
2009-09-11 |
Intekrin Therapeutics, Inc. |
Combination of a ppary agonist and a dipeptidyl peptidase-inhibitor for the treatment of diabetes and obesity
|
|
WO2009151116A1
(ja)
|
2008-06-13 |
2009-12-17 |
持田製薬株式会社 |
非アルコール性脂肪肝炎の予防／改善・治療薬
|
|
WO2010040055A2
(en)
|
2008-10-03 |
2010-04-08 |
Intekrin Therapeutics, Inc. |
Oral pharmaceutical formulations for antidiabetic compounds
|
|
JP2010265216A
(ja)
|
2009-05-14 |
2010-11-25 |
Takeda Chem Ind Ltd |
複素環化合物
|
|
EP3513790A1
(de)
|
2009-07-01 |
2019-07-24 |
JDS Therapeutics, LLC |
Chromkomplexe als enhancer von glucosetransportern im hirn
|
|
US20110034380A1
(en)
|
2009-08-05 |
2011-02-10 |
Dennis Lanfear |
Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity
|
|
BR112013007469B1
(pt)
|
2010-09-21 |
2020-03-31 |
Intekrin Therapeutics, Inc. |
Composições farmacêuticas antidiabéticas sólidas, seu uso e método de preparação, método para preparar um produto de granulação e composição precursora farmacêutica
|
|
US8477001B2
(en)
|
2010-09-21 |
2013-07-02 |
Remy Technologies Llc |
Starter solenoid with rectangular coil winding
|
|
CN103154257A
(zh)
|
2010-09-26 |
2013-06-12 |
大玉企业有限公司 |
重组大分子生成方法
|
|
WO2012071459A1
(en)
|
2010-11-22 |
2012-05-31 |
The Regents Of The University Of California |
New indication for use of niacin (nicotinic acid) for treatment, prevention and reversal of fatty liver disease
|
|
TWI435605B
(zh)
|
2010-11-29 |
2014-04-21 |
Realtek Semiconductor Corp |
透過高解析度多媒體介面來進行網路連線之網路裝置及網路連線方法
|
|
ES2389547B1
(es)
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
|
US8865641B2
(en)
|
2011-06-16 |
2014-10-21 |
The Feinstein Institute For Medical Research |
Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
|
|
WO2013052813A1
(en)
|
2011-10-06 |
2013-04-11 |
Vanderbilt University |
Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome
|
|
WO2013071077A1
(en)
*
|
2011-11-09 |
2013-05-16 |
Cornell University |
The use of pan-ppar agonists for prevention and treatment of huntington's disease and tauopathies
|
|
JP5525511B2
(ja)
|
2011-12-27 |
2014-06-18 |
農業生産法人株式会社 熱帯資源植物研究所 |
非アルコール性脂肪性肝疾患および／または非アルコール性脂肪肝炎の治療薬
|
|
WO2013134241A1
(en)
|
2012-03-05 |
2013-09-12 |
The University Of Montana |
Novel aspartylamide inhibitors of excitatory amino acid transporters
|
|
CN104903494B
(zh)
*
|
2012-09-21 |
2017-11-03 |
瑞奥可塞恩探索集团有限公司 |
用于电解液体的电池
|
|
MX2015004564A
(es)
|
2012-10-12 |
2015-07-21 |
Teva Pharma |
Laquinimod para producir el daño talamico en la esclerosis multiple.
|
|
EA201792096A3
(ru)
|
2013-01-30 |
2018-05-31 |
Интекрин Терапьютикс, Инк. |
РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА
|
|
US10441560B2
(en)
|
2013-03-15 |
2019-10-15 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
|
EP3660512B1
(de)
|
2013-03-15 |
2024-07-24 |
SomaLogic Operating Co., Inc. |
Biomarker für nichtalkoholische fettlebererkrankung und nichtalkoholische steatohepatitis und verwendungen davon
|
|
TWI696462B
(zh)
|
2013-07-10 |
2020-06-21 |
日商興和股份有限公司 |
非酒精性脂肪性肝疾病治療劑
|
|
WO2015095548A1
(en)
|
2013-12-20 |
2015-06-25 |
Teva Pharmaceutical Industries Ltd. |
Use of laquinimod to delay huntington's disease progression
|
|
US9724319B2
(en)
|
2014-02-27 |
2017-08-08 |
Nusirt Sciences, Inc. |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
EP3203999B1
(de)
|
2014-10-10 |
2020-01-08 |
Liminal Biosciences Limited |
Substituierte aromatische verbindungen und pharmazeutische zusammensetzungen zur vorbeugung und behandlung von osteoporose
|
|
CN104299589B
(zh)
|
2014-10-29 |
2016-05-25 |
京东方科技集团股份有限公司 |
移位寄存器单元电路、移位寄存器、驱动方法及显示装置
|
|
KR20160061492A
(ko)
|
2014-11-21 |
2016-06-01 |
삼성디스플레이 주식회사 |
휴대용 먼지 센서 및 이를 이용한 휴대전화
|
|
KR20220070057A
(ko)
|
2015-03-09 |
2022-05-27 |
인테크린 테라퓨틱스, 아이엔씨. |
비알코올성 지방간 질환 및/또는 지방이영양증의 치료 방법
|
|
AU2016246524B2
(en)
|
2015-04-07 |
2021-04-01 |
Intercept Pharmaceuticals, Inc. |
Pharmaceutical compositions for combination therapy
|
|
US10857209B2
(en)
|
2016-02-12 |
2020-12-08 |
Indiana University Research And Technology Corporation |
Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment
|
|
HUE053648T2
(hu)
|
2016-06-08 |
2021-07-28 |
Support Venture Gmbh |
Gyógyászati kombinációk rák kezelésére
|
|
SG11201901320WA
(en)
|
2016-08-18 |
2019-03-28 |
Intekrin Therapeutics Inc |
PPARγ AGONIST FOR TREATMENT OF BLOOD CANCERS
|
|
SG11201901328VA
(en)
|
2016-08-18 |
2019-03-28 |
Intekrin Therapeutics Inc |
Ppar? agonist for treatment of bone disorders
|
|
BR112019004791A2
(pt)
|
2016-09-13 |
2019-06-04 |
Intekrin Therapeutics Inc |
tratamento de esclerose múltipla com chs-131
|
|
US11350844B2
(en)
|
2016-11-23 |
2022-06-07 |
Mayo Foundation For Medical Education And Research |
System and method for generating nonalcoholic fatty liver disease activity score (NAS) using magnetic resonance elastography
|
|
MX2019008317A
(es)
|
2017-01-11 |
2019-09-19 |
Kowa Co |
Farmaco profilactico y terapeutico para enfermedad de higado graso no alcoholico.
|
|
AU2018210165A1
(en)
|
2017-01-18 |
2019-08-01 |
Coherus Biosciences, Inc. |
PparƳ agonist for the treatment of huntington's disease
|
|
EP3606527A1
(de)
|
2017-04-03 |
2020-02-12 |
Coherus Biosciences, Inc. |
Ppar-gamma-agonist zur behandlung der progressiven supranuklearen blickparese
|
|
US11478440B2
(en)
|
2017-04-18 |
2022-10-25 |
Genfit |
Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent
|
|
EA201992364A1
(ru)
|
2018-04-02 |
2020-03-23 |
Кохерус Байосайенсис Инк. |
АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПРОГРЕССИРУЮЩЕГО НАДЪЯДЕРНОГО ПАРАЛИЧА
|
|
JP2022516509A
(ja)
|
2018-12-31 |
2022-02-28 |
コヒラス・バイオサイエンシズ・インコーポレイテッド |
非アルコール性脂肪性肝疾患（ｎａｆｌｄ）を治療するための組成物および方法
|